All stock lists
Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
US · Delayed Price · Currency is USD
10.08-0.24 (-2.33%)
Insider Score
––Not scored
FENC Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
FENC Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 17.87 M | 15.11 M | 13.78 M | 12.46 M | 9.65 M | 8.75 M |
| Revenue Growth (YoY) | 85.18 % | 72.64 % | 73.84 % | 78.69 % | 32.91 % | -65.52 % |
| Cost of Revenue | 721.00 K | 570.00 K | 1.76 M | 660.00 K | 967.00 K | 373.00 K |
| Gross Profit | 17.15 M | 14.54 M | 12.01 M | 11.80 M | 8.69 M | 8.38 M |
| SG&A Expense | 15.30 M | 14.61 M | 14.55 M | 11.96 M | 11.31 M | 9.09 M |
| R&D Expense | 118.00 K | 49.00 K | 20.00 K | 29.00 K | 107.00 K | 94.00 K |
| Operating Expenses | 15.42 M | 14.66 M | 14.59 M | 12.00 M | 11.42 M | 9.20 M |
| Operating Income | 1.74 M | -119.00 K | -2.58 M | -201.00 K | -2.73 M | -821.00 K |
| Pretax Income | 2.02 M | 201.00 K | -4.68 M | -638.00 K | -3.15 M | -1.17 M |
| Tax Provision | 42.00 K | 0.00 | 106.00 K | 0.00 | 0.00 | 0.00 |
| Net Income | 1.97 M | 201.00 K | -4.79 M | -638.00 K | -3.15 M | -1.17 M |
| EPS (Basic) | 0.06 | 0.01 | -0.17 | -0.02 | -0.12 | -0.04 |
| EPS (Diluted) | 0.05 | 0.01 | -0.17 | -0.02 | -0.12 | -0.04 |
| Shares Outstanding | 34.55 M | 34.34 M | 31.18 M | 27.89 M | 27.66 M | 27.58 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.